Medication classes | Site 1 (CPOE) | Site 2 (HWP) | Total | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Analgesics and antipyretics (NSAIDs*a + Opiates) | 67 | 11.4 | 55 | 9.1 | 122 | 20.5 |
Antacids | 31 | 5.3 | 42 | 6.9 | 73 | 12.2 |
Antibiotics or antibacterial agents | 259 | 44 | 77 | 12.7 | 336 | 56.7 |
Anticonvulsants | 1 | 0.2 | 1 | 0.2 | 2 | 0.4 |
Antidepressants + Tranquilizers | 4 | 0.7 | 1 | 0.2 | 5 | 0.9 |
Anti-diabetic agents (Insulin and sulfonylureas) | 10 | 1.7 | 4 | 0.7 | 14 | 2.4 |
Anti-diarrheal agents | – | – | 2 | 0.3 | 2 | 0.3 |
Antiemetic | 44 | 7.5 | 96 | 15.8 | 140 | 23.3 |
Anti-flatulent | – | – | 2 | 0.3 | 2 | 0.3 |
Antihistamines | 23 | 3.9 | 13 | 2.1 | 36 | 6 |
Antineoplastic agents | 17 | 2.9 | 57 | 9.4 | 74 | 12.3 |
Antiprotozoal + Anti-leprosy agents | 14 | 2.4 | 4 | 0.7 | 18 | 3.1 |
Antiviral | – | – | 3 | 0.5 | 3 | 0.5 |
Appetite stimulants | – | – | 5 | 0.8 | 5 | 0.8 |
Benzodiazepine antagonists | 4 | 0.7 | – | – | 4 | 0.7 |
Bisphosphonates | – | – | 8 | 1.3 | 8 | 1.3 |
Blood derivatives | – | – | 2 | 0.3 | 2 | 0.3 |
Bronchodilators + Immunosuppressive agents + Mast cell stabilizers + Xanthine oxidase inhibitors | 1 | 0.2 | – | – | 1 | 0.2 |
Cardiac drug + ACEIs*b + Calcium antagonists + Cardiac glycosides | – | – | 4 | 0.7 | 4 | 0.7 |
Cathartics/Laxatives | 13 | 2.2 | 13 | 2.1 | 26 | 4.3 |
CNS depressants + Sedatives, hypnotics and Anxiolytics (Barbiturates and Benzodiazepines) | 10 | 1.7 | 24 | 4 | 34 | 5.7 |
Coagulants and Anticoagulants | 19 | 3.2 | 8 | 1.3 | 27 | 4.5 |
Colony stimulating factor (CSF) | 9 | 1.5 | 5 | 0.8 | 14 | 2.3 |
Cyto-protectants (Mesna) | – | – | 6 | 1 | 6 | 1 |
Devices | – | – | 2 | 0.3 | 2 | 0.3 |
Dietary supplements and Vitamins | 7 | 1.2 | 72 | 11.9 | 79 | 13.1 |
Diuretics | – | – | 11 | 1.8 | 11 | 1.8 |
Enzymes | – | – | 1 | 0.2 | 1 | 0.2 |
Expectorants | – | – | 5 | 0.8 | 5 | 0.8 |
Human albumin | – | – | 7 | 1.2 | 7 | 1.2 |
Immunomodulatory agents | – | – | 3 | 0.5 | 3 | 0.5 |
Monoclonal antibodies | – | – | 5 | 0.9 | 5 | 0.9 |
Mouth washes and gargles | 12 | 2 | – | – | 12 | 2 |
Ointments/Solutions/Suspensions ophthalmic + Otic/Ophthalmic/Nasal preparations | 7 | 1.2 | 4 | 0.7 | 11 | 1.9 |
Opiates | – | – | 1 | 0.2 | 1 | 0.2 |
Para-sympatholytic agents | 4 | 0.7 | – | – | 4 | 0.7 |
Quinolones | – | – | 3 | 0.5 | 3 | 0.5 |
Replacement solutions/ORS*c/Minerals/Elements/Electrolytes | 16 | 2.7 | 24 | 4 | 40 | 6.7 |
Skeletal muscle relaxants | 4 | 0.7 | – | – | 4 | 0.7 |
Steroids | 4 | 0.7 | 11 | 1.8 | 15 | 2.5 |
Sugar/Salt substitutes | 2 | 0.3 | 14 | 2.3 | 16 | 2.6 |
Sympathomimetic agents | 7 | 1.2 | 2 | 0.3 | 9 | 1.5 |
Thrombolytic agents | – | – | 4 | 0.7 | 4 | 0.7 |
Uricosuric agents | – | – | 3 | 0.5 | 3 | 0.5 |
Total | 589 | 100 | 606 | 100 | 1195 | Â |